Live feed
·
INSIDERFiling
C4 Therapeutics Inc. logo

Chief Financial Officer Adams Kendra was granted 240,000 shares, converted options into 34,700 shares and covered exercise/tax liability with 17,244 shares, increasing direct ownership by 137% to 385,098 units (SEC Form 4)